Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Tonge

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 1, 2015
Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductaseHui Wang, Li Liu, Yang Lu, et al.
ACS Infectious Diseases|April 23, 2019
Antibacterial Activity and Mode of Action of a Sulfonamide-Based Class of Oxaborole Leucyl-tRNA-Synthetase InhibitorsYuanyuan Si, Sneha Basak, Yong Li, et al.
Chemical Science|May 17, 2017
A quantitative mechanistic PK/PD model directly connects Btk target engagement and <i>in vivo</i> efficacyFereidoon Daryaee, Zhuo Zhang, Kayla R Gogarty, et al.
Journal of Medicinal Chemistry|July 31, 2024
Biological Evaluation of d-[<sup>18</sup>F]Fluoroalanine and d-[<sup>18</sup>F]Fluoroalanine-<i>d</i><sub>3</sub> as Positron Emission Tomography Imaging Tracers for Bacterial InfectionKaixuan Li, Jinnette Tolentino Collado, Jocelyn A Marden, et al.
Chembiochem : a European Journal of Chemical Biology|November 24, 2011
Stable analogues of OSB-AMP: potent inhibitors of MenE, the o-succinylbenzoate-CoA synthetase from bacterial menaquinone biosynthesisXuequan Lu, Rong Zhou, Indrajeet Sharma, et al.
European Journal of Medicinal Chemistry|October 18, 2016
Antitubercular activity of 1,2,3-triazolyl fatty acid derivativesDiego G Ghiano, Agustina de la Iglesia, Nina Liu, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
The Burkholderia pseudomallei enoyl-acyl carrier protein reductase FabI1 is essential for in vivo growth and is the target of a novel chemotherapeutic with efficacyJason E Cummings, Luke C Kingry, Drew A Rholl, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 22, 2008
Inhibiting enoyl-ACP reductase (FabI) across pathogenic microorganisms by linear sesquiterpene lactones from Anthemis auriculataAnastasia Karioti, Helen Skaltsa, Xujie Zhang, et al.
The Journal of Biological Chemistry|October 3, 2006
Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coliSalma Rafi, Polina Novichenok, Subramaniapillai Kolappan, et al.
European Journal of Medicinal Chemistry|September 14, 2014
Radiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureusHui Wang, Yang Lu, Li Liu, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|August 1, 2015
Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductaseHui Wang, Li Liu, Yang Lu, et al.
ACS Infectious Diseases|April 23, 2019
Antibacterial Activity and Mode of Action of a Sulfonamide-Based Class of Oxaborole Leucyl-tRNA-Synthetase InhibitorsYuanyuan Si, Sneha Basak, Yong Li, et al.
Chemical Science|May 17, 2017
A quantitative mechanistic PK/PD model directly connects Btk target engagement and <i>in vivo</i> efficacyFereidoon Daryaee, Zhuo Zhang, Kayla R Gogarty, et al.
Journal of Medicinal Chemistry|July 31, 2024
Biological Evaluation of d-[<sup>18</sup>F]Fluoroalanine and d-[<sup>18</sup>F]Fluoroalanine-<i>d</i><sub>3</sub> as Positron Emission Tomography Imaging Tracers for Bacterial InfectionKaixuan Li, Jinnette Tolentino Collado, Jocelyn A Marden, et al.
Chembiochem : a European Journal of Chemical Biology|November 24, 2011
Stable analogues of OSB-AMP: potent inhibitors of MenE, the o-succinylbenzoate-CoA synthetase from bacterial menaquinone biosynthesisXuequan Lu, Rong Zhou, Indrajeet Sharma, et al.
European Journal of Medicinal Chemistry|October 18, 2016
Antitubercular activity of 1,2,3-triazolyl fatty acid derivativesDiego G Ghiano, Agustina de la Iglesia, Nina Liu, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
The Burkholderia pseudomallei enoyl-acyl carrier protein reductase FabI1 is essential for in vivo growth and is the target of a novel chemotherapeutic with efficacyJason E Cummings, Luke C Kingry, Drew A Rholl, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 22, 2008
Inhibiting enoyl-ACP reductase (FabI) across pathogenic microorganisms by linear sesquiterpene lactones from Anthemis auriculataAnastasia Karioti, Helen Skaltsa, Xujie Zhang, et al.
The Journal of Biological Chemistry|October 3, 2006
Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coliSalma Rafi, Polina Novichenok, Subramaniapillai Kolappan, et al.
European Journal of Medicinal Chemistry|September 14, 2014
Radiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureusHui Wang, Yang Lu, Li Liu, et al.
Pageof 17